Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity

Hypertrophic cardiomyopathy in a lupus patient: a case of hydroxychloroquine cardiotoxicity

Abstract Hydroxychloroquine (HCQ) is a well‐established and effective immunomodulatory therapy for systemic lupus erythematosus and other autoimmune diseases. While retinal toxicity is a well‐recognized complication, cardiotoxicity is lesser known. This case consists of a 63‐year‐old Filipina on chr...

Full description

Bibliographic Details
Main Authors: Amanda Chang, Gabriel Stolin, Judith Fan, Boris R. Larreta, Gregory A. Fishbein, William Dean Wallace, Arnold S. Baas, Daniel Cruz, Jessica Wang
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:ESC Heart Failure
Subjects:
Hydroxychloroquine
Hypertrophic cardiomyopathy
Variant of uncertain significance
Minority
Myeloid bodies
Online Access:https://doi.org/10.1002/ehf2.12508

Internet

https://doi.org/10.1002/ehf2.12508

Similar Items